Developing and Submitting Proposed Draft Guidance Relating to Patient Experience Data
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 21, 2018
April 23, 2020
49677313-1014-4cd6-be89-f28a08eb3f96
Related Documents
Container Closure Systems for Human Drugs and Biological Products
Guidance DocumentAugust 13, 2026Center for Drug Evaluation and Research
Considerations for Complying with 21 CFR 211110
Guidance DocumentJanuary 6, 2025Center for Drug Evaluation and Research
Neovascular Age-Related Macular Degeneration: Developing Drugs for Treatment
Guidance DocumentFebruary 24, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.